We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $127B Turnover 40.17%
1-Year Est. Return 46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
Cap. Flow
+$9.28B
Cap. Flow %
7.32%
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held Equity + Options
1 year
Top 10 Avg Time Held Equity + Options
2.3 years
Top 20 Avg Time Held Equity + Options
1.6 years
Avg Time Held Equity only
1 year
Top 10 Avg Time Held Equity only
2.4 years
Top 20 Avg Time Held Equity only
1.6 years

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$9.9B
2
COST icon
Costco
COST
+$907M
3
ABBV icon
AbbVie
ABBV
+$643M
4
JPM icon
JPMorgan Chase
JPM
+$609M
5
BAC icon
Bank of America
BAC
+$567M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.03B
2
MELI icon
Mercado Libre
MELI
+$528M
3
AVGO icon
Broadcom
AVGO
+$514M
4
SNDK icon
Sandisk
SNDK
+$507M
5
MRVL icon
Marvell Technology
MRVL
+$499M

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.91%
2 Technology 20.64%
3 Consumer Discretionary 9.1%
4 Healthcare 8.21%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BUR icon
2151
Burford Capital
BUR
$714M
$1.04M ﹤0.01%
253,255
-246,536
-49% -$1.13M
2023 Q4
10 quarters
NIQ icon
2152
NIQ Global Intelligence PLC
NIQ
$5.87B
$1.04M ﹤0.01%
111,032
-72,180
-39% -$698K
2026 Q1
1 quarter
VLTO icon
2153
Veralto
VLTO
$25.2B
$1.02M ﹤0.01%
11,528
-49,412
-81% -$4.29M
2026 Q1
1 quarter
WYNN icon
2154
Wynn Resorts
WYNN
$7.64B
$1.02M ﹤0.01%
10,471
-6,964
-40% -$718K
2026 Q1
1 quarter
PRLD icon
2155
Prelude Therapeutics
PRLD
$295M
$1.02M ﹤0.01%
190,692
-168,214
-47% -$732K
2025 Q4
2 quarters
PNR icon
2156
Pentair
PNR
$8.81B
$1.02M ﹤0.01%
13,252
-136,247
-91% -$10.8M
2025 Q4
2 quarters
CSL icon
2157
Carlisle Companies
CSL
$13.7B
$1.02M ﹤0.01%
2,800
-18,333
-87% -$6.42M
2026 Q1
1 quarter
DDOG icon
2158
CALL
Datadog
DDOG
$101B
$1.02M ﹤0.01%
3,900
-7,600
-66% -$1.41M
2026 Q1
1 quarter
HNI icon
2159
HNI Corp
HNI
$3.44B
$1.01M ﹤0.01%
25,105
-3,387
-12% -$115K
2025 Q3
3 quarters
HTZ icon
2160
Hertz
HTZ
$692M
$1.01M ﹤0.01%
446,896
-5,134,509
-92% -$28M
2024 Q2
8 quarters
TTEK icon
2161
Tetra Tech
TTEK
$9.5B
$1.01M ﹤0.01%
35,094
-684,524
-95% -$20.1M
2025 Q4
2 quarters
HRTX icon
2162
Heron Therapeutics
HRTX
$57.1M
$1.01M ﹤0.01%
+2,354,193
New +$1.89M
2026 Q2
0 quarters
TFII icon
2163
TFI International
TFII
$9.19B
$1.01M ﹤0.01%
+7,042
New +$994K
2026 Q2
0 quarters
ZVRA icon
2164
Zevra Therapeutics
ZVRA
$566M
$1.01M ﹤0.01%
70,286
-369,666
-84% -$4.11M
2025 Q3
3 quarters
CMCSA icon
2165
Comcast
CMCSA
$78.3B
$1.01M ﹤0.01%
40,981
+40,919
+65,998% +$1.06M
2025 Q1
5 quarters
SBS icon
2166
Sabesp
SBS
$16.6B
$1M ﹤0.01%
173,556
-862,264
-83% -$5.22M
2025 Q3
3 quarters
MRLN icon
2167
Merlin Inc
MRLN
$86.8M
$1M ﹤0.01%
+176,099
New +$1.49M
2026 Q2
0 quarters
ADAC icon
2168
American Drive Acquisition Co
ADAC
$1M ﹤0.01%
100,000
– –
2026 Q1
1 quarter
MESH icon
2169
Meshflow Acquisition Corp
MESH
$435M
$1M ﹤0.01%
100,000
– –
2026 Q1
1 quarter
IYT icon
2170
iShares US Transportation ETF
IYT
$1.92B
$991K ﹤0.01%
11,426
+3,726
+48% +$305K
2025 Q4
2 quarters
SPRY icon
2171
ARS Pharmaceuticals
SPRY
$390M
$991K ﹤0.01%
123,714
+18,708
+18% +$161K
2024 Q3
7 quarters
DERM icon
2172
Journey Medical
DERM
$140M
$990K ﹤0.01%
+139,843
New +$799K
2026 Q2
0 quarters
ZIM icon
2173
ZIM Integrated Shipping Services
ZIM
$3.56B
$989K ﹤0.01%
38,053
-879,019
-96% -$22.7M
2026 Q1
1 quarter
AMWL icon
2174
American Well
AMWL
$230M
$985K ﹤0.01%
108,057
+64,012
+145% +$478K
2024 Q3
7 quarters
CPB icon
2175
Campbell Soup
CPB
$6.15B
$985K ﹤0.01%
+44,224
New +$933K
2026 Q2
0 quarters

Similar funds

Marshall Wace's Q2 2026 Portfolio in Review

As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.

  • Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
  • Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
  • Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
  • Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
  • Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
  • Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.